Immunogenicity and Safety of an Inactivated COVID-19 Vaccine
Clinical trial NCT04953325 · COMPLETED
Trial details
- NCT number
- NCT04953325
- Sponsor
- Sinovac Research and Development Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-09
- Primary completion
- 2021-10-31
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.